Demographic and Clinical Characteristics
| Characteristic | Group before treatment | Group after treatment |
| No. of patients | 108 | 103 |
| Age (y) | 51 (54) ± 19 (12–83) | 55 (59) ± 18 (17–84) |
| Sex | ||
| Male | 43 | 43 |
| Female | 65 | 60 |
| Weight (kg) | 80 (75) ± 19 (46–144) | 81 (80) ± 18 (44–129) |
| Height (cm) | 169 (168) ± 9 (148–192) | 169 (169) ± 9 (150–195) |
| Blood volume (L) | 4.61 (4.25) ± 0.90 (3.14–7.40) | 4.65 (4.49) ± 0.86 (3.21–6.85) |
| TNM* | ||
| Tx/T1/T2/T3/T4 | 4/10/15/13/66 | 7/7/26/17/46 |
| N0/N1 | 46/62 | 39/64 |
| M0/M1 | 78/30 | 61/42 |
| Histology (papillary/follicular) | 83/25 | 59/44 |
| Diffuse pulmonary metastases | 17 | 8 |
| TSH stimulation (endogenous/exogenous) | 87/21 | 54/49 |
| TSH level (mIU/L) | 85 (77) ± 45 (25–259) | 106 (104) ± 50 (25–240) |
| 124I activity (MBq) | 23 (22) ± 5 (18–50) | 26 (22) ± 8 (18–49) |
↵* TNM, initial tumor staging according to fifth UICC classification.
Statistics are provided in the following form: mean (median) ± SD (minimum to maximum).